Detailansicht

Wissensnetz

Person

Claus Rödel (1966-)

Arzt

Name	Claus Rödel
Zeit	1966- (Lebensdaten)
Ort	Bamberg (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf) Hochschullehrer
Variante	C. Rödel Claus Roedel Claus M. Rödel Claus Michael Rödel
Beziehung	Klinikum Frankfurt am Main Universität Heidelberg Strahlentherapie (Thema)
Weitere Angaben	Facharzt für Strahlentherapie; Klinischer Direktor des Universitären Centrums für Tumorerkrankungen (UCT) Frankfurt
Quelle	Homepage: https://www.kgu.de/einrichtungen/kliniken/zentrum-der-radiologie/strahlentherapie/unsere-klinik/mitarbeiter/aerztliches-personal/roedel/lebenslauf-prof-roedel (Stand: 15.12.2021)
Datensatztyp	Person
GND-Nummer	1152978330
Datensatz-ID	1152978330
Beteiligt an alle anzeigen Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models Die Carboanhydrase IX repräsentiert ein potenzielles therapeutisches Zielmolekül in der Eradikation von Tumor-initiierenden Zellen des Schilddrüsenkarzinoms Dual-Energy-CT-basierte Rho/Z-Karten zur Differenzierung von hypodensen Leberläsionen bei Patienten mit malignem Melanom Kombinierte Radiochemotherapie mit Protonen : Evaluation des therapeutischen Ansprechens von Tumor Organoiden des Adenokarzinoms des Pankreas Development and validation of a predictive model for toxicity of neoadjuvant chemoradiotherapy in rectal cancer in the CAO/ARO/AIO-04 phase III trial Individuelle Dosimetrie der Nieren bei der Therapie des metastasierten kastrationsresistenten Prostatakarzinoms mit 177Lu-Prostataspezifischem Membranantigen (177Lu-PSMA) mittels konventioneller nuklearmedizinischer Diagnostik Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial : Early Surrogate Endpoints Revisited Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models C-reactive protein to albumin ratio as prognostic marker in locally advanced non-small cell lung cancer treated with chemoradiotherapy Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy Neoadjuvant chemoradiotherapy for oral cavity cancer: predictive factors for response and interim analysis of the prospective INVERT-Trial Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patients Correction to: Value of PET imaging for radiation therapy Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial Value of PET imaging for radiation therapy Value of PET imaging for radiation therapy Patterns of care, toxicity and outcome in the treatment of salivary gland carcinomas: long-term experience from a tertiary cancer center Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1 High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer. oncological outcomes after a median 15-year follow-up Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer Kurzzeitstrahlentherapie mit 5 × 5 Gy gefolgt von präoperativer Chemotherapie und Resektion bei Patienten mit lokal fortgeschrittenen Rektumkarzinomen führt zu einer Verbesserung des krankheitsfreien Überlebens = Short-term radiotherapy with 5 × 5 Gy followed by preoperative chemotherapy and resection in patients with locally advanced rectal carcinoma results in improved disease-free survival Molecular markers to predict prognosis and treatment response in uterine cervical cancer Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice Patterns of care, toxicity and outcome in the treatment of salivary gland carcinomas: long-term experience from a tertiary cancer center Radioimmunotherapy: future prospects from the perspective of brachytherapy Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patients Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial Tumor suppressor protein p53 and inhibitor of apoptosis proteins in colorectal cancer — a promising signaling network for therapeutic interventions Value of PET imaging for radiation therapy Value of PET imaging for radiation therapy Urologische Prostatakrebsvorsorge im Rahmen der Movember-Gesundheitsinitiative 2019 am Universitätsklinikum Frankfurt Einfluss der Behandlungscompliance auf den Erfolg der Radiochemotherapie des Analkarzinoms Management of anal cancer patients – a pattern of care analysis in German-speaking countries Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – Interdisziplinäre Empfehlungen Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer – Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society Einfluss der Behandlungscompliance auf den Erfolg der Radiochemotherapie des Analkarzinoms Fractionation-dependent radiosensitization by molecular targeting of Nek1 Maintenance of energy homeostasis during calorically restricted ketogenic diet and fasting-MR-spectroscopic insights from the ERGO2 trial RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: a randomized multicenter phase II trial Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT) Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review Sarcopenia is associated with hematologic toxicity during chemoradiotherapy in patients with anal carcinoma Urologische Prostatakrebsvorsorge im Rahmen der Movember-Gesundheitsinitiative 2019 am Universitätsklinikum Frankfurt Adrenal insufficiency in patients with corticosteroid-refractory cerebral radiation necrosis treated with bevacizumab C-reactive protein-to-albumin ratio as prognostic marker for anal squamous cell carcinoma treated with chemoradiotherapy Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK) Peripheral leukocytosis is inversely correlated with intratumoral CD8+ t-cell infiltration and associated with worse outcome after chemoradiotherapy in anal cancer Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer Definitive, preoperative, and palliative radiation therapy of esophageal cancer The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Claus Rödel (1966-)

Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models

Die Carboanhydrase IX repräsentiert ein potenzielles therapeutisches Zielmolekül in der Eradikation von Tumor-initiierenden Zellen des Schilddrüsenkarzinoms

Dual-Energy-CT-basierte Rho/Z-Karten zur Differenzierung von hypodensen Leberläsionen bei Patienten mit malignem Melanom

Kombinierte Radiochemotherapie mit Protonen : Evaluation des therapeutischen Ansprechens von Tumor Organoiden des Adenokarzinoms des Pankreas

Development and validation of a predictive model for toxicity of neoadjuvant chemoradiotherapy in rectal cancer in the CAO/ARO/AIO-04 phase III trial

Individuelle Dosimetrie der Nieren bei der Therapie des metastasierten kastrationsresistenten Prostatakarzinoms mit 177Lu-Prostataspezifischem Membranantigen (177Lu-PSMA) mittels konventioneller nuklearmedizinischer Diagnostik

Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial : Early Surrogate Endpoints Revisited

Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy

ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group

Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models

C-reactive protein to albumin ratio as prognostic marker in locally advanced non-small cell lung cancer treated with chemoradiotherapy

Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy

Neoadjuvant chemoradiotherapy for oral cavity cancer: predictive factors for response and interim analysis of the prospective INVERT-Trial

Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited

Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies

Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patients

Correction to: Value of PET imaging for radiation therapy

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

Value of PET imaging for radiation therapy

Value of PET imaging for radiation therapy

Patterns of care, toxicity and outcome in the treatment of salivary gland carcinomas: long-term experience from a tertiary cancer center

Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer. oncological outcomes after a median 15-year follow-up

Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view

Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer

Molecular markers to predict prognosis and treatment response in uterine cervical cancer

Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice

Patterns of care, toxicity and outcome in the treatment of salivary gland carcinomas: long-term experience from a tertiary cancer center

Radioimmunotherapy: future prospects from the perspective of brachytherapy

Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patients

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

Tumor suppressor protein p53 and inhibitor of apoptosis proteins in colorectal cancer — a promising signaling network for therapeutic interventions

Value of PET imaging for radiation therapy

Value of PET imaging for radiation therapy

Urologische Prostatakrebsvorsorge im Rahmen der Movember-Gesundheitsinitiative 2019 am Universitätsklinikum Frankfurt

Einfluss der Behandlungscompliance auf den Erfolg der Radiochemotherapie des Analkarzinoms

Management of anal cancer patients – a pattern of care analysis in German-speaking countries

Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – Interdisziplinäre Empfehlungen

Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer – Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society

Einfluss der Behandlungscompliance auf den Erfolg der Radiochemotherapie des Analkarzinoms

Fractionation-dependent radiosensitization by molecular targeting of Nek1

Maintenance of energy homeostasis during calorically restricted ketogenic diet and fasting-MR-spectroscopic insights from the ERGO2 trial

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: a randomized multicenter phase II trial

Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)

Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review

Sarcopenia is associated with hematologic toxicity during chemoradiotherapy in patients with anal carcinoma

Urologische Prostatakrebsvorsorge im Rahmen der Movember-Gesundheitsinitiative 2019 am Universitätsklinikum Frankfurt

Adrenal insufficiency in patients with corticosteroid-refractory cerebral radiation necrosis treated with bevacizumab

C-reactive protein-to-albumin ratio as prognostic marker for anal squamous cell carcinoma treated with chemoradiotherapy

Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors

Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)

Peripheral leukocytosis is inversely correlated with intratumoral CD8+ t-cell infiltration and associated with worse outcome after chemoradiotherapy in anal cancer

Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer

Definitive, preoperative, and palliative radiation therapy of esophageal cancer

The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis

HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)